angioplasty

(redirected from facilitated angioplasty)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to facilitated angioplasty: Percutaneous coronary intervention, STEMI
click for a larger image
angioplasty
balloon angioplasty

an·gi·o·plas·ty

 (ăn′jē-ə-plăs′tē)
n. pl. an·gi·o·plas·ties
Surgical repair of a blood vessel, especially the widening of a narrowed blood vessel by means of balloon angioplasty.

angioplasty

(ˈændʒɪəˌplæstɪ)
n
(Surgery) a surgical technique for restoring normal blood flow through an artery narrowed or blocked by atherosclerosis, either by inserting a balloon into the narrowed section and inflating it or by using a laser beam

an•gi•o•plas•ty

(ˈæn dʒi əˌplæs ti)

n., pl. -ties.
the surgical repair of a blood vessel, as by inserting a balloon-tipped catheter to unclog it or by replacing part of the vessel.
[1925–30]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.angioplasty - an operation to repair a damaged blood vessel or unblock a coronary artery
surgical operation, surgical procedure, surgical process, surgery, operation - a medical procedure involving an incision with instruments; performed to repair damage or arrest disease in a living body; "they will schedule the operation as soon as an operating room is available"; "he died while undergoing surgery"
Translations

angioplasty

n (Med) → Angioplastie f

an·gi·o·plas·ty

n. angioplastia, intervención quirúrgica para la reconstrucción de vasos sanguíneos enfermos o traumatizados;
percutaneous coronary ______ coronaria percutánea;
peripheral percutaneous ______ periférica percutánea.

angioplasty

n (pl -ties) angioplastia; percutaneous transluminal coronary — (PTCA) angioplastia coronaria transluminal percutánea (ACTP)
References in periodicals archive ?
Randomized comparison between tirofiban and abciximab to promote complete ST-resolution in primary angioplasty: results of the facilitated angioplasty with tirofiban or abciximab (FATA) in ST-elevation myocardial infarction trial.
Left ventricular function after ST elevation myocardial infarction in patients treated with primary percutaneous coronary intervention and abciximab or tirofiban (from the facilitated angioplasty with tirofiban or abciximab [FATA] trial).
The researchers found that, 30 days after the heart attack, 16% of patients who did not have facilitated angioplasty either had died, suffered another heart attack, or needed an urgent procedure to reopen the artery, compared with 5.